3-Pyrroline containing arylacetamides: a novel series of remarkably selective kappa-agonists

Bioorg Med Chem Lett. 2002 Sep 2;12(17):2287-90. doi: 10.1016/s0960-894x(02)00429-8.

Abstract

A series of 2-(substituted phenyl)-N-methyl-N-[(1S)-1-(substituted alkyl)-2-(1-(3-pyrrolinyl))ethyl]acetamides were synthesized and evaluated as highly selective kappa-agonists with K(i) values in low nanomolar range. 3-Pyrroline incorporated into the basic amino functionality in combination with 2-(methylthio)ethyl substituent on the carbon adjacent to the amide nitrogen remarkably enhanced the kappa-selectivity. 3,4-Dichlorophenyl derivative 1e was found the most potent and selective analgesic in this series with ED(50) value of 0.023 mg/kg.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetamides / administration & dosage
  • Acetamides / chemical synthesis
  • Acetamides / pharmacology*
  • Analgesics, Opioid / administration & dosage
  • Analgesics, Opioid / chemical synthesis*
  • Analgesics, Opioid / pharmacology
  • Animals
  • Humans
  • Injections, Intraperitoneal
  • Pain / drug therapy
  • Pyrroles / chemistry
  • Radioligand Assay
  • Rats
  • Receptors, Opioid, kappa / agonists*
  • Structure-Activity Relationship

Substances

  • Acetamides
  • Analgesics, Opioid
  • Pyrroles
  • Receptors, Opioid, kappa
  • pyrroline